drugset / Trial / NCT00876694
Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to collect long term safety data of indacaterol (300 µg o.d.) in Japanese patients with moderate to severe COPD. Data from this study will be used for the registration of indacaterol in Japan.
Timeline
- Start
- 2009-03
- Primary completion
- 2010-10
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indacaterol | Other / unclassified | 300 ug | Inhaled |
| Comparator | Salmeterol | Other / unclassified | 50 ug | Inhaled |